Wellgistics Health Inc (WGRX)
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
$3.59+15.06%
Close 2026-07-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
QuarterlyIQ Insights · WGRX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 291.2% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of — · Company calendar date is not available
WGRX — dividend update
Dated 2026-08-14
Other Events. As previously announced by Data MEDS AI, Inc. (the “ Company ”) and Datavault AI Inc., a Delaware corporation (“ Datavault ”), Datavault will be making a voluntary one-time distribution (the “ Distribution ”) of Dream Bowl 2026 Meme Coin tokens (such tokens, the “ Meme Coins ”) to the record holders of DataMEDS common stock, par value $0.0001 per share (such stock, the “ DataMEDS Common Stock ” and such record holders, the “ Record Holders ”) as of the close of business on Augus…
Why it matters: This expansion could help Wellgistics manage data better. It may also increase revenue.
Supportive ifA deal is made to expand the PharmacyChain license. It will add Health-as-a-Service features.
Worry ifDiscussions stall or fail to result in a binding agreement.
Why it matters: A big change in value may show how the market sees the company. It can also reflect how well the company is doing.
Watch forThe valuation score goes up a lot from 31.1.
Also watch forValuation score decreases from the current 31.1.
Why it matters: New partnerships can drive growth and improve market position. They signal business expansion.
Supportive ifNew partnerships or deals may be announced soon.
Worry ifNo new partnerships announced in the next quarter.
Why it matters: Fixing the delisting notice is important for staying in the market. It impacts investor trust.
Watch forCompany says it follows Nasdaq listing rules.
Also watch forFurther notice of non-compliance from Nasdaq.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$535 on $10,000 · ±5.4% | How much price usually moves either way. |
| Bad day | $1,561 loss on $10,000 · 15.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,694 loss on $10,000 · 96.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: This revenue target shows if the company can sustain its growth. Meeting this target would confirm positive momentum.
Supportive ifQ2 2026 revenue reported at or above $1.775 million.
Worry ifQ2 2026 revenue reported below $1.775 million.
Why it matters: This app launch is key for expanding patient engagement and revenue. Success could validate the company's strategy.
Supportive ifThe Health Lives Here app launches as scheduled in August 2026.
Worry ifThe app launch is delayed or canceled.